No increase in prostate cancer with testosterone therapy

Men with low levels of testosterone need not fear that replacement therapy will increase their risk of prostate cancer, according to a study of more than a quarter of a million Swedish men.

The researchers found those prescribed testosterone for longer than a year had no overall increase in risk of prostate cancer and, in fact, had their risk of aggressive disease reduced by 50%.